Radiodermatitis Market

Global Radiodermatitis Market Size, Share, Growth Analysis, By Product(Topical, Corticosteroids), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy) - Industry Forecast 2023-2030


Report ID: SQMIG35G2240 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 72 | Figures: 66

Global Radiodermatitis Market Insights

Radiodermatitis Market size was valued at USD 517.44 Million in 2021 and is poised to grow from USD 539.17 million in 2022 to USD 749.32 million by 2030, growing at a CAGR of 4.2% during the forecast period (2023-2030).

The demand for radiodermatitis treatment products is more critical than ever before due to the urgency in addressing this negative consequence. Radiodermatitis, which includes erythema, dry desquamation, and moist desquamation, affects a substantial 95% of cancer patients undergoing radiation therapy. Notably, 85-95% of breast cancer patients receiving radiotherapy also experience varying degrees of radiodermatitis.

The COVID-19 pandemic initially disrupted the radiodermatitis market, particularly in the radiation oncology departments, as healthcare institutions prioritized COVID-19 patients. This led to a decline in weekly radiation sessions in 2020 compared to the same months in 2019. However, with the easing of lockdowns and restrictions in various regions and the implementation of safe cancer treatment measures by cancer institutes, growth opportunities have emerged for the market in the post-COVID-19 period.

Furthermore, the increasing prevalence of diabetes and obesity has contributed to the rising cases of cancer. The Centers for Disease Control estimates that there were 34.2 million cases of diabetes worldwide in 2018, and this number is expected to reach 1.2 billion by 2030. As a result, a larger population of patients is at higher risk of developing cancer, and their co-morbid conditions make them more susceptible to radiation-induced skin damage. This trend is anticipated to drive the market's growth during the forecast period.

US Radiodermatitis Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2023-2030

Global Market Size

USD 517.44 Million

Largest Segment

Retail Pharmacies

Fastest Growth

Retail Pharmacies

Growth Rate

4.2% CAGR

Radiodermatitis Market ($ Bn)
Country Share for Asia Pacific Region (%)
Radiodermatitis Market by Distribution Channel ($ Bn)
Radiodermatitis Market by Distribution Channel (%)

To get more reports on the above market click here to Buy The Report

Global Radiodermatitis Market Segmental Analysis

The radiodermatitis market is segmented on the basis of product, distribution channel, and region. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future. Based on Product the market is segmented as, topical, corticosteroids, hydrophilic creams, topical antibiotics, others, oral drugs, dressings, hydrogel and hydrocolloid dressings, no sting barrier film, honey impregnated gauze, silicone coated, and others. Based on distribution channel the market is segmented as, hospital pharmacy, retail pharmacy, and online pharmacy. Based on Region the market is segmented as, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Radiodermatitis Market Analysis By Product

In 2022, the topical product segment emerged as the dominant player in the market, accounting for a substantial share of nearly 71.3%. This significant portion can be attributed to the numerous advantages offered by topical products. These benefits, which have driven their widespread acceptance in previous years, include ease of use, accessibility, and cost-efficiency. Moreover, topical products reduce the risk of microbiological transmission and protect the skin from abrasive substances. Key items within this category include topical antibiotics, hydrophilic lotions, and corticosteroids. Among these, corticosteroids, known for their efficacy in treating inflammatory skin disorders, have been widely adopted for radiodermatitis treatment, contributing to the segment's dominance.

Dressings are expected to achieve a moderate growth rate in the upcoming years, primarily due to the wide variety of products available in the market. These dressings include foam-based, hydrogel & hydrocolloid, silicone-coated, silver-leaf dressings, and others. Dressings have been proven effective in treating various grades of radiation burns, which is expected to drive their adoption in the coming years. Hydrogel and hydrocolloid dressings, in particular, are gaining popularity due to their quick healing properties, minimal discomfort, and high level of protection against infection and bacterial growth. The accessibility of a diverse range of dressing options, each catering to specific patient needs, is anticipated to further expand growth opportunities in this market segment.

Radiodermatitis Market Analysis By Distribution

In 2022, retail pharmacies emerged as the leading distribution channel segment, holding a significant share of 39.3%. The dominance of retail stores can be attributed to their high accessibility and cost-effectiveness. Drug cost reimbursement schemes encourage patients to rely on retail pharmacies, contributing to market growth by increasing affordability.

Online pharmacies are expected to experience exponential growth rates during the projection period due to several advantages they offer. For customers who prefer not to purchase medications from retail or hospital pharmacies, online pharmacies provide added convenience. Additionally, the rising prevalence of chronic diseases has created a demand-supply gap for essential pharmaceuticals, further driving the demand for online pharmacies.

By offering easy order procurement and tracking for customers, online pharmacies enhance convenience. Moreover, their associated supply chain management (SCM) streamlines the distribution process by eliminating some intermediaries, leading to reduced drug prices. This cost-effectiveness and convenience drive more customers to opt for online medicine purchases, contributing to the growth of this distribution channel in the market.

Radiodermatitis Market by Distribution Channel, 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Radiodermatitis Market Regional Insights

In 2022, Asia Pacific dominated the market, accounting for 46.0% of the total market share. This significant share can be attributed to the increasing number of cancer patients in the region, driving the demand for radiodermatitis treatments. Moreover, key businesses in the region have engaged in substantial collaborations to expand their product range, further bolstering their market presence. Renowned pharmaceutical firms in the region actively promote their products, contributing to higher end-user adoption rates. Favorable government initiatives that support research activities and the increasing outsourcing by industrialized economies also act as key growth drivers for the Asia Pacific market.

North America held the second-largest share of the market. This market's growth is primarily driven by the substantial research and development investments made by global players, aiming to achieve a competitive edge in the market. Additionally, the region's high disposable income and advanced healthcare infrastructure create significant growth opportunities in the radiodermatitis market.

Radiodermatitis Market By Geography, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Radiodermatitis Market Dynamics

Radiodermatitis Market Drivers

Growing Adoption of Radiation Therapy

  • The increasing adoption of radiation therapy for cancer treatment contributes to the higher incidence of radiodermatitis cases. As radiation therapy becomes more widely used, the demand for radiodermatitis treatments also increases

Radiodermatitis Market Restraints

Side Effects and Adverse Reactions

  • Some radiodermatitis treatments may have side effects or adverse reactions, limiting their use in certain patient populations and potentially impacting market growth.

Request Free Customization of this report to help us to meet your business objectives.

Global Radiodermatitis Market Competitive Landscape

The reports highlight significant developments in the radiodermatitis market, encompassing both organic and inorganic growth strategies. Companies in the global radiodermatitis market are employing organic growth strategies such as product launches, approvals, patents, and events to expand their presence during the forecast period. In parallel, inorganic growth strategies such as acquisitions, partnerships, and collaborations have facilitated business expansion and increased customer base. Radiodermatitis market players are expected to find lucrative growth opportunities in the global market due to the rising demand. Below is a list of companies actively involved in the radiodermatitis market.

Radiodermatitis Market Top Player’s Company Profile

  • 3M COMPANY
  • BAUSCH HEALTH COMPANIES INC
  • BAYER AG
  • BMG PHARMA SPA
  • CONVATEC GROUP PLC
  • GLAXOSMITHKLINE PLC
  • HELSINN HEALTHCARE SA
  • MOLNLYCKE HEALTH CARE
  • MYLAN N.V.
  • SMITH & NEPHEW PLC
  • STRATPHARMA AG

Radiodermatitis Market Recent Developments

  • On May 4, 2023, Albert Einstein College of Medicine, U.S explained a simple antibacterial treatment solves a severe skin problem caused by radiation therapy, Staphylococcus aureus (SA), often shortened to "staph", usually lives harmlessly on the skin, often in the nose and armpits. But they can cause infections if the skin of the incision breaks. Radiation weakens the skin structure at the treatment site and can cause infection, allowing SA to penetrate the outer layer of the skin.
  • In January 2021, Integra Lifesciences Holdings Inc. acquired ACell Inc. and its proprietary MatriStem UBMTM technology to further enhance its complex wound management solutions.

Global Radiodermatitis Key Market Trends

  • Increasing Adoption of Advanced Treatment Options: The market is witnessing a growing adoption of advanced treatment options for radiodermatitis. Topical products, dressings, and other innovative therapies are gaining popularity due to their effectiveness in managing radiation-induced skin damage.

Global Radiodermatitis Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global Radiodermatitis Market analysis, the increasing prevalence of cancer and the widespread adoption of radiation therapy as a treatment option. Advanced treatment options, favorable reimbursement policies, and growing awareness among healthcare professionals are driving market expansion. Technological advancements in radiation therapy and strategic collaborations among key players are further contributing to market growth. Additionally, the expansion of healthcare infrastructure in emerging markets is enhancing the accessibility of radiodermatitis treatments, leading to promising opportunities in the industry. This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future. Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

Report Metric Details
Market size value in 2021 USD 517.44 Million
Market size value in 2030 USD 749.32 million
Growth Rate 4.2%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Million
Segments covered
  • Product
    • Topical, Corticosteroids, Hydrophilic Creams, Topical Antibiotics, Others, Oral Drugs, Dressings, Hydrogel and Hydrocolloid Dressings, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated, and Others
  • Distribution Channel
    • Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • 3M COMPANY
  • BAUSCH HEALTH COMPANIES INC
  • BAYER AG
  • BMG PHARMA SPA
  • CONVATEC GROUP PLC
  • GLAXOSMITHKLINE PLC
  • HELSINN HEALTHCARE SA
  • MOLNLYCKE HEALTH CARE
  • MYLAN N.V.
  • SMITH & NEPHEW PLC
  • STRATPHARMA AG
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Radiodermatitis Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Radiodermatitis Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Radiodermatitis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Radiodermatitis Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Radiodermatitis Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Radiodermatitis Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Radiodermatitis Market size was valued at USD 517.44 Million in 2021 and is poised to grow from USD 539.17 million in 2022 to USD 749.32 million by 2030, growing at a CAGR of 4.2% during the forecast period (2023-2030).

The reports highlight significant developments in the radiodermatitis market, encompassing both organic and inorganic growth strategies. Companies in the global radiodermatitis market are employing organic growth strategies such as product launches, approvals, patents, and events to expand their presence during the forecast period. In parallel, inorganic growth strategies such as acquisitions, partnerships, and collaborations have facilitated business expansion and increased customer base. Radiodermatitis market players are expected to find lucrative growth opportunities in the global market due to the rising demand. Below is a list of companies actively involved in the radiodermatitis market. '3M COMPANY', 'BAUSCH HEALTH COMPANIES INC', 'BAYER AG', 'BMG PHARMA SPA', 'CONVATEC GROUP PLC', 'GLAXOSMITHKLINE PLC', 'HELSINN HEALTHCARE SA', 'MOLNLYCKE HEALTH CARE', 'MYLAN N.V.', 'SMITH & NEPHEW PLC', 'STRATPHARMA AG'

The increasing adoption of radiation therapy for cancer treatment contributes to the higher incidence of radiodermatitis cases. As radiation therapy becomes more widely used, the demand for radiodermatitis treatments also increases

Increasing Adoption of Advanced Treatment Options: The market is witnessing a growing adoption of advanced treatment options for radiodermatitis. Topical products, dressings, and other innovative therapies are gaining popularity due to their effectiveness in managing radiation-induced skin damage.

In 2022, Asia Pacific dominated the market, accounting for 46.0% of the total market share. This significant share can be attributed to the increasing number of cancer patients in the region, driving the demand for radiodermatitis treatments. Moreover, key businesses in the region have engaged in substantial collaborations to expand their product range, further bolstering their market presence. Renowned pharmaceutical firms in the region actively promote their products, contributing to higher end-user adoption rates. Favorable government initiatives that support research activities and the increasing outsourcing by industrialized economies also act as key growth drivers for the Asia Pacific market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Radiodermatitis Market

Product ID: SQMIG35G2240

$5,300
BUY NOW GET FREE SAMPLE